TCW Group’s Bristol-Myers Squibb BMY Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | $2.04M | Buy |
33,646
+1,627
| +5% | +$94.8K | 0.02% | 275 |
|
|
2025
Q4 | $1.73M | Buy |
+32,019
| New | +$1.54M | 0.01% | 293 |
|
|
2025
Q3 | – | Sell |
-30,826
| Closed | -$1.43M | – | 255 |
|
|
2025
Q2 | $1.43M | Buy |
30,826
+642
| +2% | +$31.5K | 0.01% | 276 |
|
|
2025
Q1 | $1.84M | Sell |
30,184
-7,155
| -19% | -$417K | 0.02% | 260 |
|
|
2024
Q4 | $2.11M | Buy |
37,339
+721
| +2% | +$40.3K | 0.02% | 252 |
|
|
2024
Q3 | $1.89M | Sell |
36,618
-664
| -2% | -$31.1K | 0.02% | 259 |
|
|
2024
Q2 | $1.55M | Buy |
37,282
+374
| +1% | +$16.7K | 0.01% | 285 |
|
|
2024
Q1 | $2M | Sell |
36,908
-4,740
| -11% | -$241K | 0.02% | 244 |
|
|
2023
Q4 | $2.13M | Buy |
+41,648
| New | +$2.19M | 0.02% | 247 |
|
|
2020
Q1 | – | Sell |
-49,702
| Closed | -$3.19M | – | 308 |
|
|
2019
Q4 | $3.19M | Buy |
49,702
+15,643
| +46% | +$896K | 0.04% | 187 |
|
|
2019
Q3 | $1.73M | Hold |
34,059
| – | – | 0.02% | 215 |
|
|
2019
Q2 | $1.54M | Buy |
34,059
+6,900
| +25% | +$321K | 0.02% | 222 |
|
|
2019
Q1 | $1.3M | Hold |
27,159
| – | – | 0.01% | 226 |
|
|
2018
Q4 | $1.41M | Hold |
27,159
| – | – | 0.01% | 240 |
|
|
2018
Q3 | $1.69M | Sell |
27,159
-7
| -0% | -$415 | 0.01% | 242 |
|
|
2018
Q2 | $1.5M | Hold |
27,166
| – | – | 0.01% | 243 |
|
|
2018
Q1 | $1.72M | Buy |
27,166
+1,750
| +7% | +$113K | 0.01% | 234 |
|
|
2017
Q4 | $1.56M | Hold |
25,416
| – | – | 0.01% | 236 |
|
|
2017
Q3 | $1.62M | Hold |
25,416
| – | – | 0.01% | 248 |
|
|
2017
Q2 | $1.42M | Hold |
25,416
| – | – | 0.01% | 264 |
|
|
2017
Q1 | $1.38M | Sell |
25,416
-123,250
| -83% | -$6.76M | 0.01% | 265 |
|
|
2016
Q4 | $8.69M | Sell |
148,666
-12,834
| -8% | -$702K | 0.07% | 154 |
|
|
2016
Q3 | $8.71M | Sell |
161,500
-4,965
| -3% | -$319K | 0.07% | 150 |
|
|
2016
Q2 | $12.2M | Buy |
166,465
+17,134
| +11% | +$1.21M | 0.09% | 132 |
|
|
2016
Q1 | $9.54M | Sell |
149,331
-5
| -0% | -$315 | 0.07% | 141 |
|
|
2015
Q4 | $10.3M | Buy |
149,336
+2,555
| +2% | +$169K | 0.07% | 140 |
|
|
2015
Q3 | $8.69M | Sell |
146,781
-5,100
| -3% | -$324K | 0.06% | 145 |
|
|
2015
Q2 | $10.1M | Sell |
151,881
-357,629
| -70% | -$23.6M | 0.07% | 166 |
|
|
2015
Q1 | $32.9M | Buy |
509,510
+16,679
| +3% | +$1.04M | 0.16% | 132 |
|
|
2014
Q4 | $29.1M | Sell |
492,831
-345,200
| -41% | -$19.5M | 0.12% | 139 |
|
|
2014
Q3 | $42.9M | Sell |
838,031
-3,019
| -0.4% | -$151K | 0.17% | 132 |
|
|
2014
Q2 | $40.8M | Buy |
841,050
+13,350
| +2% | +$658K | 0.17% | 131 |
|
|
2014
Q1 | $43M | Sell |
827,700
-8,150
| -1% | -$434K | 0.18% | 112 |
|
|
2013
Q4 | $44.4M | Buy |
835,850
+1,050
| +0.1% | +$53.5K | 0.19% | 111 |
|
|
2013
Q3 | $38.6M | Buy |
834,800
+7,443
| +0.9% | +$327K | 0.18% | 111 |
|
|
2013
Q2 | $37M | Buy |
+827,357
| New | +$35.9M | 0.18% | 107 |
|
Other funds holding BMY
VCM
VPM
TCW Group's BMY Position: Q1 2026 in Review
TCW Group increased its Bristol-Myers Squibb (BMY) stake by 5.1% in Q1 2026, buying an estimated $94.8K and bringing the position to 33,646 shares worth $2.04M. The position accounts for 0.02% of the portfolio, ranked #275.
TCW Group first reported a position in BMY in Q2 2013 and has held it in 36 quarters since. The position peaked at $44.4M in Q4 2013. 2,518 funds tracked by Wall St. Rank hold BMY as of Q1 2026.
- TCW Group held 33,646 shares of Bristol-Myers Squibb worth $2.04M as of Q1 2026.
- TCW Group bought 1,627 Bristol-Myers Squibb shares in Q1 2026, an estimated $94.8K.
- Bristol-Myers Squibb made up 0.02% of TCW Group's portfolio in Q1 2026, its #275 holding.
- TCW Group first reported a position in Bristol-Myers Squibb in Q2 2013 and has held it in 36 quarters since.
- TCW Group's Bristol-Myers Squibb position peaked at $44.4M in Q4 2013.
- 2,518 funds tracked by Wall St. Rank held Bristol-Myers Squibb as of Q1 2026.
Based on TCW Group's 13F filing for Q1 2026, filed 14 May 2026.